Eight studies related to breast cancer (Oktay et al., 2006; Lutchman Singh et al., 2007; Yu et al., 2010; Bala et al., 2016; Pereira et al., 2016; Quinn et al., 2017; Goldrat et al., 2019; Porcu et al., 2020), with four studies reporting serum AMH levels (Yu et al., 2010; Bala et al., 2016; Pereira et al., 2016; Goldrat et al., 2019), two studies separately reporting basal FSH hormone levels and AFC values (Oktay et al., 2006; Quinn et al., 2017), and two studies reporting multiple ovarian reserve parameters (e.g. AMH, inhibin B, and AFC) (Lutchman Singh et al., 2007; Porcu et al., 2020). This evidence concerns the gene AMH and breast carcinoma.